Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2011

Mar 15, 2011

34519_dirs_2011-03-15_81e9097a-7f33-428f-8743-7bc2f59bdfef.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2011-03-11

Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-03-11 Common Stock, par value $0.10 per share P 820 $3.12 Acquired 463170 Direct
2011-03-15 Common Stock, par value $0.10 per share P 600 $3.25 Acquired 463770 Direct

Footnotes

F1: This figure includes 214,155 shares of common stock held by Arterio, Inc., a company solely owned by Mr. Rothschild.